Elion Therapeutics, a biotechnology company dedicated to transforming the treatment of life-threatening invasive fungal infections (IFIs), has closed a $81 million Series B funding round led by Deerfield Management and the AMR Action Fund. Additional investors include Illinois Ventures.
Constructor, the only AI product discovery platform designed explicitly for e-commerce retailers, has raised $25M in Series B funding, bringing the company’s valuation to $550M.
Relay, the cloud-based communications platform designed to improve productivity and safety for frontline teams, secures $35 million in series B round funding.
This round was...
Sware, provider of the most complete software validation solution for innovative life sciences companies, secures $6million in series B round funding, bringing its total...
Torpago, a commercial credit card and spend management provider, secures $10million in series B round funding. Leading the round were EJF Ventures and Priority...
Transcend, a data privacy platform provider, secures $40million in series B round funding. New investor StepStone Group led the round, which raised a total...
Braavo Capital Inc, the leading financing partner for consumer subscription apps, secures $5 million in series B round funding.
This capital infusion, which is being...
Hydrolix, a streaming data lake platform, secures $35million in series B round funding. With the participation of previous investors like Nava Ventures, Wing Ventures,...
